DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Butallylonal
Butallylonal
(12) Patent Application Publication (10) Pub. No.: US 2004/0224012 A1 Suvanprakorn Et Al
Partial Agreement in the Social and Public Health Field
(12) United States Patent (10) Patent No.: US 9.205,048 B2 Lichter Et Al
Perspectives in Drug Discovery a Collection of Essays on the History and Development of Pharmaceutical Substances
(12) Patent Application Publication (10) Pub. No.: US 2003/0068365A1 Suvanprakorn Et Al
201 PART 329—HABIT-FORMING DRUGS Subpart A—Derivatives
Laws and Regulations Promulgated to Give Effect to the Provisions of the International Treaties on Narcotic Drugs and Psychotropic Substances
List of Controlled Drugs and Permitted Quantities)
Council of Europe Committee of Ministers (Partial
(12) Patent Application Publication (10) Pub. No.: US 2008/0008748A1 Beyreuther Et Al
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
THE EDINBURGH GAZETTE 13 FEBRUARY 1987 197 (A) on Each
The Barbiturates in Forensic Chemistry Dissertation
Fdrlrgse O.5,N.16/Mnajl ,18 Oie Federal Register / Vol. 50, No. 126
Resolution Ap (77) 1
ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
(12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
Outcome of Suprarefractory Status Epilepticus
Top View
Forensic Toxicology Controlled Substances and Dangerous Drugs Forensic Toxicology Controlled Substances and Dangerous Drugs
ICD-10-CM TABLE of DRUGS and CHEMICALS
Controlled Drugs List
202 PART 329—HABIT-FORMING DRUGS Subpart A—Derivatives
Table of Drugs and Chemicals (FY12)
(19) United States (12) Patent Application Publication (10) Pub
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
AC 91.11-1, Guide to Drug Hazards in Aviation Medicine
201 PART 329—HABIT-FORMING DRUGS Subpart A—Derivatives
United States Patent (19) 11) Patent Number: 5,656,286 Miranda Et Al
The Controlled Drugs and Substances
Wo 2009/132050 A9
SYNTHESIS of BARBITURIC ACID DERIVATIVES a THESIS Presented
The Treatment of Super-Refractory Status Epilepticus: a Critical Review of Available Therapies and a Clinical Treatment Protocol
Inductive QSAR Descriptors. Distinguishing Compounds with Antibacterial Activity by Artificial Neural Networks